J B Chemicals and Pharmaceuticals Ltd
JBCHEPHARMJ B Chemicals and Pharmaceuticals Ltd
JBCHEPHARM
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 45.67 | 9.55 | 0.68% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.53 | 6.56 | 0.52% |
Forecast & Ratings
Detailed Forecast from 13 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets a range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredient (APIs).
Investor Presentation
View olderPeers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,268.43 | 1,394.45 | 1,445.49 | 1,684.64 | 1,825.40 | 2,154.90 | 2,463.47 | 3,159.22 | 3,521.45 | 3,751.08 | ||||||||||
Raw Materials | 483.71 | 519.54 | 544.41 | 615.76 | 634.79 | 742.76 | 860.38 | 1,179.20 | 1,228.90 | 2,739.13 | ||||||||||
| Power & Fuel Cost | 55.28 | 54.89 | 58.28 | 63.29 | 61.54 | 62.60 | 71.47 | 91.54 | 88.08 | |||||||||||
| Employee Cost | 175.31 | 217.34 | 251.10 | 288.18 | 322.92 | 340.60 | 439.24 | 543.45 | 601.41 | |||||||||||
| Selling & Administrative Expenses | 157.42 | 174.28 | 205.31 | 234.51 | 228.72 | 233.56 | 358.90 | 448.81 | 501.94 | |||||||||||
| Operating & Other expenses | 132.62 | 145.85 | 131.98 | 135.62 | 159.19 | 102.59 | 150.79 | 190.53 | 166.96 | |||||||||||
EBITDA | 264.09 | 282.55 | 254.41 | 347.28 | 418.24 | 672.79 | 582.69 | 705.69 | 934.16 | 1,011.95 | ||||||||||
| Depreciation/Amortization | 41.22 | 47.22 | 56.97 | 55.64 | 66.32 | 68.67 | 72.66 | 114.41 | 138.32 | 157.43 | ||||||||||
| PBIT | 222.87 | 235.33 | 197.44 | 291.64 | 351.92 | 604.12 | 510.03 | 591.28 | 795.84 | 854.52 | ||||||||||
| Interest & Other Items | 10.65 | 5.37 | 3.49 | 4.65 | 3.03 | 7.24 | 5.12 | 36.05 | 44.33 | 29.60 | ||||||||||
| PBT | 212.22 | 229.96 | 193.95 | 286.99 | 348.89 | 596.88 | 504.91 | 555.23 | 751.51 | 824.92 | ||||||||||
| Taxes & Other Items | 49.68 | 45.88 | 55.61 | 93.52 | 76.85 | 148.92 | 119.54 | 145.40 | 198.88 | 213.79 | ||||||||||
| Net Income | 162.54 | 184.08 | 138.34 | 193.47 | 272.04 | 447.96 | 385.37 | 409.83 | 552.63 | 611.13 | ||||||||||
| EPS | 9.58 | 10.85 | 8.22 | 11.81 | 17.27 | 28.98 | 24.93 | 26.50 | 35.66 | 39.38 | ||||||||||
| DPS | 2.50 | 0.50 | 1.00 | 2.50 | 5.50 | 8.25 | 8.25 | 8.88 | 12.25 | 12.25 | ||||||||||
| Payout ratio | 0.26 | 0.05 | 0.12 | 0.21 | 0.32 | 0.28 | 0.33 | 0.33 | 0.34 | 0.31 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFInvestor Presentation
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| J B Chemicals and Pharmaceuticals Ltd | 50.50 | 9.55 | 0.68% |
| Sun Pharmaceutical Industries Ltd | 45.35 | 6.47 | 0.75% |
| Cipla Ltd | 28.51 | 4.38 | 0.89% |
| Torrent Pharmaceuticals Ltd | 68.45 | 16.54 | 0.84% |
Price Comparison
Compare JBCHEPHARM with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Increased Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has increased by 1.46%
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding J B Chemicals and Pharmaceuticals Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
Axis Small Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.7249% | Percentage of the fund’s portfolio invested in the stock 1.98% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 7/136 (+29) |
Kotak Emerging Equity Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.7222% | Percentage of the fund’s portfolio invested in the stock 0.92% | Change in the portfolio weight of the stock over the last 3 months 0.04% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 55/78 (0) |
Franklin India Smaller Companies Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.0179% | Percentage of the fund’s portfolio invested in the stock 2.04% | Change in the portfolio weight of the stock over the last 3 months 0.11% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 6/103 (0) |
Compare 3-month MF holding change on Screener
smallcases
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have J B Chemicals and Pharmaceuticals Ltd
Events
Dividend Trend
No Dividend Cuts
JBCHEPHARM has increased or maintained dividend levels over the last 5 years
Dividend Yield
Current dividend yield is 0.68%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹6.81 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateAug 14, 2024
Dividend/Share
₹6.75
Ex DateEx Date
Aug 14, 2024
Cash Dividend
Ex DateEx DateFeb 16, 2024
Dividend/Share
₹5.50
Ex DateEx Date
Feb 16, 2024
Cash Dividend
Ex DateEx DateAug 17, 2023
Dividend/Share
₹9.25
Ex DateEx Date
Aug 17, 2023
Cash Dividend
Ex DateEx DateFeb 17, 2023
Dividend/Share
₹8.50
Ex DateEx Date
Feb 17, 2023
Cash Dividend
Ex DateEx DateAug 12, 2022
Dividend/Share
₹8.00
Ex DateEx Date
Aug 12, 2022
J B Chemicals & Pharmaceuticals has allotted 102,900 equity shares under ESOS on 06 December 2024. Consequently, the issued, subscribed and paid up capital has increased from 15,54,09,708 equity shares of Re. 1 each to 15,55,12,608 equity shares of Re. 1 each. Powered by Capital Market - Live
J B Chemicals & Pharmaceuticals Ltd is up for a third straight session today. The stock is quoting at Rs 1770.95, up 1.58% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 1.57% on the day, quoting at 24282.7. The Sensex is at 80152.78, up 1.31%. J B Chemicals & Pharmaceuticals Ltd has slipped around 5.27% in last one month. Meanwhile, Nifty Pharma index of which J B Chemicals & Pharmaceuticals Ltd is a constituent, has slipped around 2.85% in last one month and is currently quoting at 21962.05, up 1.11% on the day. The volume in the stock stood at 67778 shares today, compared to the daily average of 1.3 lakh shares in last one month.The PE of the stock is 44.88 based on TTM earnings ending September 24.Powered by Capital Market - Live
J B Chemicals & Pharmaceuticals Ltd fell for a fifth straight session today. The stock is quoting at Rs 1715.25, down 3.61% on the day as on 12:59 IST on the NSE. The benchmark NIFTY is down around 0.94% on the day, quoting at 23659.1. The Sensex is at 78018.99, down 0.83%.J B Chemicals & Pharmaceuticals Ltd has eased around 6.32% in last one month.Meanwhile, Nifty Pharma index of which J B Chemicals & Pharmaceuticals Ltd is a constituent, has eased around 7.95% in last one month and is currently quoting at 22151.6, down 1.6% on the day. The volume in the stock stood at 55393 shares today, compared to the daily average of 1.48 lakh shares in last one month.The PE of the stock is 46.07 based on TTM earnings ending September 24.Powered by Capital Market - Live
Net profit of J B Chemicals & Pharmaceuticals rose 15.92% to Rs 174.57 crore in the quarter ended September 2024 as against Rs 150.59 crore during the previous quarter ended September 2023. Sales rose 13.48% to Rs 1000.62 crore in the quarter ended September 2024 as against Rs 881.74 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1000.62881.74 13 OPM %27.0427.62 - PBDT278.41240.83 16 PBT236.53208.66 13 NP174.57150.59 16 Powered by Capital Market - Live
J B Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 November 2024Powered by Capital Market - Live
J B Chemicals & Pharmaceuticals has allotted 69,850 equity shares under ESOS on 26 August 2024. Consequently, the issued, subscribed and paid up capital has increased from 15,52,24,558 equity shares of Re. 1 each to 15,52,94,408 equity shares of Re. 1 each. Powered by Capital Market - Live
J B Chemicals & Pharmaceuticals Ltd is up for a third straight session in a row. The stock is quoting at Rs 1966.75, up 1.09% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.11% on the day, quoting at 24164.4. The Sensex is at 79148.73, up 0.24%. J B Chemicals & Pharmaceuticals Ltd has added around 10.21% in last one month. Meanwhile, Nifty Pharma index of which J B Chemicals & Pharmaceuticals Ltd is a constituent, has added around 5.41% in last one month and is currently quoting at 22191.6, down 0.99% on the day. The volume in the stock stood at 81368 shares today, compared to the daily average of 1.54 lakh shares in last one month.The PE of the stock is 52.69 based on TTM earnings ending June 24.Powered by Capital Market - Live
Net profit of J B Chemicals & Pharmaceuticals rose 24.25% to Rs 176.83 crore in the quarter ended June 2024 as against Rs 142.32 crore during the previous quarter ended June 2023. Sales rose 12.07% to Rs 1004.40 crore in the quarter ended June 2024 as against Rs 896.20 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales1004.40896.20 12 OPM %27.9125.90 - PBDT280.62225.68 24 PBT239.84194.30 23 NP176.83142.32 24 Powered by Capital Market - Live
J B Chemicals & Pharmaceuticals has allotted 11,500 equity shares under ESOS on 08 August 2024. Consequently, the issued, subscribed and paid up capital has increased from 155,213,058 equity shares of Re. 1 each to 155,224,558 equity shares of Re. 1 each. Powered by Capital Market - Live
Technical Breakout Stocks: Sun Pharma, Ajanta Pharma and JB Chemicals hit record high when Sensex falls 2,200 points - Market Roundup
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 15.89%, vs industry avg of 9.03%
Increasing Market Share
Over the last 5 years, market share increased from 0.77% to 0.93%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 23.36%, vs industry avg of 15.27%